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Methods. Five tongue squamous cell carcinomas cell lines and 1 submaxillary salivary gland epidermoid carcinoma cell line were analyzed for copy number and mRNA expression by tiling-path DNA microarrays and Agilent Whole Human Genome Oligoarrays, respectively.
Results. Integrative analysis of genetic and expression alterations revealed the molecular landscape of each cell line. Molecular results for individual cell lines and across all samples have been summarized and made available for easy reference.
Conclusion. Our integrative genomic analyses have defined the DNA and RNA alterations for each individual line. These data will be useful to anyone modeling oral cancer behavior, providing a molecular context that will be useful for deciphering cell phenotypes. Keywords: oral cancer; head and neck cancer; cell models; copy number alteration; RNA expression alteration Head and neck squamous cell carcinoma (HNSCC) is the eighth most common cancer in the world. 1 It is a heterogeneous disease primarily affecting the oral cavity, salivary glands, oropharynx, hypopharynx, and larynx. Model systems, such as cell lines, are often used as research tools to study many cancer types, including HNSCC. 2, 3 They allow for manipulation of tumor cells in a laboratory setting. However, tumorigenic cell lines in such studies have often not been fully characterized at the molecular level. Like tumors themselves, cancer cell lines can vary greatly with respect to their genetic background. Analysis of cell phenotypes without concurrent analysis of underlying molecular changes represents a lost opportunity to understand the mechanistic basis for disease.
One characteristic of most solid tumors is genomic instability. This is demonstrated by the numerous DNA gains and deletions present in tumor genomes. 4 DNA alterations can lead to aberrant expression of oncogenes and tumor suppressor genes that drive tumorigenesis. For HNSCC development, gene alterations such as loss of chromosomes 3p and 9p, mutation of p53, loss of 13q, and high-level amplification of CCND1 have been associated with premalignant disease stages. [5] [6] [7] [8] Loss of chromosomes 4q and 8p, on the other hand, are believed to occur as later events in tumorigenesis. 9 Such DNA alterations, including high-level amplification of CCND1, 10 often leads to overexpression, while homozygous deletion of CDKN2A leads to silencing of p16
INK4A in oral tumors.
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Established HNSCC cell lines-particularly SCC-4, SCC-9, SCC-15, SCC-25, A253, and Cal27-are widely used as models of head and neck cancer. A preliminary search in PubMed reveals 407 publications that use at least 1 of these lines, demonstrating their importance as tools for modeling biochemical, immunologic, and pharmacologic behaviors. These various behaviors could be influenced by the molecular alterations that exist in each line, yet few efforts have been made to characterize such changes. Previously, genetic alterations of 4 of the oral squamous cell carcinoma (OSCC) cell lines (SCC-4, SCC-9, SCC-15, and SCC-25) have been characterized by cDNA microarrays with low resolution and with no data on intragenic regions. 12 Thus, comprehensive characterization of genomic alterations in the most commonly used cell models are needed. In addition, a priori knowledge of both genomic and gene expression changes for a given cell line would facilitate selection of the most appropriate model system for a given in vitro analysis. In this report, we provide full characterization of genome and transcriptome alterations in 6 commonly used HNSCC cell lines. These data will serve as an excellent resource when designing future experiments that attempt to model HNSCC behavior.
MATERIALS AND METHODS
Cell Lines. Five tongue squamous cell carcinomas cell lines (SCC-4, 13 SCC-9, 13 SCC-25,
13
SCC-15, 13 and Cal27
14
) and 1 submaxillary salivary gland epidermoid carcinoma cell line (A-253) 15 were purchased from the American Type Culture Collection (ATCC). All cell lines were cultured according to ATCC recommendations. Cells were harvested for DNA and RNA extractions when they reached approximately 80% confluency. Genomic DNA was extracted by the standard phenol-chloroform extraction protocol, and total RNA was extracted using the TRIzol (Invitrogen, Carlsbad, CA) protocol followed by DNase I treatment.
Tiling-Path DNA Microarray. Extracted DNA from each cell line was analyzed by whole genome tiling-path microarrays (SMRT v. 2) developed at the British Columbia Cancer Research Centre Array Laboratory. 16 For this array, the whole genome is represented as more than 26,000 overlapping bacterial artificial chromosome (BAC) clones spotted in duplicate with tiling coverage of the human genome. Pooled normal male DNA was used as reference for all microarray experiments. Labeling, hybridization, scanning, and washing of the slides were performed as previously described. 8 Imaging and Analysis of Genomic Data. Array images were analyzed with GenePix Pro 6.1. A 3-step normalization procedure, including locally weighted linear regression (LOWESS) fitting, spatial, and median normalization was used to remove systematic biases. 17 SeeGH software was used to combine duplicate spot data and display log 2 signal intensity ratios in relation to genomic locations in the hg18 assembly (NCBI Build 36.1). 18 Data points with standard deviation >0.075 and signal to noise ratio <3 in either channel were removed from each sample.
Two separate algorithms, aCGH-Smooth and DNACopy, were used to detect copy number gains and losses. 19, 20 An alteration was only called when detected concurrently by both algorithms. The aCGH-Smooth employs a local search algorithm that uses a maximum likelihood estimation to smooth the observed array of comparative genomic hybridization (CGH) values between consecutive breakpoints to a common value. 19 The Lambda and the maximum number of breakpoints in the initial pool were set to 6.75 and 100 respectively. 8 DNAcopy employs a circular binary segmentation algorithm that uses a random permutation test to determine the statistical significance of change points. 20 Default settings in DNAcopy were used for our data.
A third algorithm based on moving-average was used for the identification of high-level DNA amplification and presumptive homozygous deletions. 21 The threshold was set at log 2 signal intensity ratio >0.8 for high-level amplification or <À0.8 for homozygous deletions. Only regions containing !3 overlapping clones with such calls were identified in order to avoid falsepositives due to hybridization artifacts.
Gene Expression Profiling. Total RNA collected from each cell line was analyzed by Agilent Whole Human Genome Microarray 4 Â 44,000. This array represents more than 41,000 unique human transcripts. Labeling and hybridizations were performed according to the manufacturer's instructions (Agilent Technologies). Hybridized arrays were scanned using Axon GenePix 4000B and 4200A scanner.
Data Analysis of Expression Profiles. Array images were analyzed using GenePix Pro 6.1. For normalization processing, each backgroundsubtracted intensity value was divided by the median array intensity of each microarray. The median array intensity was calculated based on the background-subtracted intensity value for all spots excluding control type spots on the array. Genes within regions of high-level copy number change were extracted for each cell line. Oral cell lines with no high-level copy number change serve as the baseline for the genes in each alteration region and the mean of each median-normalized intensity value of each probe was compared with those of the cell lines with high-level change.
RESULTS AND DISCUSSION
Cancer cell lines are important model systems for investigating the biology of head and neck cancers. They allow for characterization of a variety of disease phenotypes and also serve as a tool for functional screens. When using such models, it is imperative to determine how closely the model resembles clinical disease. However, genome-wide characterization of most cell lines has not previously been attempted. Characterizing DNA alterations in these cells and determining the contribution of these changes to mRNA expression would provide a very valuable reference point for interpreting experimental results generated using these cell lines. The set of 6 genomic and 6 expression profiles has been deposited to Gene Expression Omnibus (GEO) database at NCBI, series accession number GSE16872.
High-level DNA amplification is a common mechanism for driving overexpression of oncogenes, while homozygous deletion is known to inactivate tumor suppressor genes and also contribute to cancer processes. [21] [22] [23] High-resolution genomic analysis delineates the precise boundaries of amplified or deleted regions, thus defining genes that warrant further investigation. Parallel analysis of gene expression data from the same cells helps to differentiate between ''driver'' and ''passenger'' genes in a given segmental DNA change, the former being genes that contribute to the cancer phenotype, the latter being altered simply due to its proximity to a ''driver'' gene. 21, 24 For example, any candidate gene in an amplicon that is not overexpressed is unlikely to represent a ''driver'' gene. Figure 1 displays a summary of altered regions detected in each oral cell line, while the specific base pair positions are listed in Supplemental Tables S1 to S6. Furthermore, as this paper serves as a reference, the copy number status of well known cancer genes obtained from the Cancer Gene Census is catalogued in Table 1 . 25 Whole genome copy number karyogram of each cell line and description of each cell line is represented in Supplemental Figure S1 .
It is known that head and neck cancers, like many solid tumors, are a molecularly heterogeneous group where several regions of alteration and genes have been reported at high frequencies but may occur in various combinations in a given tumor. Genetic alterations frequently occurring in tumors indicate an importance for carcinogenesis. Loss of chromosome 3p and 9p are genetic events frequently documented in head and neck tumors, and both have been implicated as 1 of the earliest changes in oral premalignant lesions and associated with progression risks.
6,9 All 6 cell lines revealed segmental losses of chromosome 3p and 9p (detailed regions of genetic alterations are listed in Supplemental Tables S1-S6). The Cal27 revealed only 1 region of segmental loss of 9p24.1-p23, while the remaining 5 cell lines exhibited copy number loss at 9p21.3, which contain the tumor suppressor CDKN2A. Genetic loss of chromosome 8p is also an expected change that has been frequently described in clinical specimens. 26, 27 Whole arm 8p loss was found in SCC-15, SCC-9, Cal27, while A253 exhibited a region of homozygous deletion on 8p23.2-p23.2 and a region of high-level DNA amplification on 8p22. Gain of chromosome 8q is also a frequent genetic alteration in head and neck tumors, harboring the known oncogene MYC. 26 Cell lines A253, SCC-15, SCC-4, SCC-25, and SCC-9 all showed low-level gain of 8q24 (MYC). Regions of high-level amplification, including 3q26, 7p11, and 11q13, occur frequently in head and neck tumors. [26] [27] [28] [29] [30] These regions have been associated with PIK3CA, EGFR, and CCND1, respectively. SCC-4 and SCC-9 did not reveal genetic gain of 3q26.32, whereas the lines A253, SCC-15, and SCC-25 showed low level gains. Cell lines SCC-15 and Cal27 exhibited the region of high-level amplification at the EGFR locus, and cell lines SCC-4, SCC-9, and A-253 exhibited low-level copy number gain. Cell lines SCC-9 and Cal27 showed genetic gain of the CCND1 locus, whereas 4 cell lines A253, SCC-15, SCC-4, and SCC-25 displayed high-level amplification of this locus. Complex alterations on chromosome arm 11q were revealed SCC-15, SCC-4, SCC-25, and A253 ( Figure 2 ).
One common characteristic of the cell lines is the presence of high-level amplifications, where many of the lines contained multiple regions of high-level DNA amplification. This is similar to tumor genomes where it has been reported that high-level amplification is observed in approximately 65% of cases, although usually only 1 or 2 regions per tumor. 26 High-level amplifications indicating multiple copy numbers and regions of homozygous deletion, where both copies are lost, often result in gene overexpression and underexpression. 21, 22, 31 These types of alteration often arise under selective pressure of genes important for the growth of cancer cells. Therefore, we focused our analysis on the expression of genes within these regions. The expression levels of genes within all the regions of high-level DNA amplification and homozygous deletion detected in the 6 cell lines are presented in 
Mitogen-activated protein kinase kinase 4 
Oligodendrocyte lineage transcription factor 2 (BHLHB1)
Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa Supplemental Figure S2 . In general, regions of homozygous deletion often resulted in lower expression levels for many of the genes within the region, while a higher level of expression was often observed in at least 1 gene within an amplicon compared to cell lines without such amplicon. For example, a common region of high-level amplification of 4.15 Mbp in size on 11p13-p12 was detected in Cal27 and A-253, which contains 20 RefSeq genes ( Figure 3 ). The expression of 17 of these genes was analyzed, and the gene CD44 has a 2-fold increase in expression compared with the other 4 cell lines without such high-level amplification. Other genes inside this amplicon, PDHX and CAT, also have a 5-fold increase in expression. The expression of CD44 is also among the top 5-percentile of all expressed genes in the 6 cell lines, suggesting that while high-level DNA amplification causes higher expression of the gene, other mechanisms might also cause its high expression in cell lines without such amplicon. However, as there are many ways to regulate gene expression, some of the amplified regions do not show the expected changes in gene expression. Further molecular examinations of epigenetic alterations and sequence analyses would be essential to fully characterize the different molecular aspects of each cell line.
CONCLUSIONS
Head and neck cancer cell lines are important model systems for investigating head and neck cancer biology. Comprehensive characterization of their genetic alterations is useful for the selection and interpretation of studies using cell lines. Our data present the first comprehensive catalogue of copy number and expression alterations in 6 commonly used and easily obtainable oral cancer cell lines, thus providing a good resource for researchers to select and use these cell lines in experiments.
